Rilonacept is a prescription medication used to treat chronic recurrent pericarditis, a type of inflammation of the sac surrounding the heart. It is a recombinant fusion protein that inhibits the activity of interleukin-1, an important mediator of inflammation. Rilonacept is given as a subcutaneous injection once a month. Common side effects of rilonacept include injection site reactions, headache, fatigue, nausea, and diarrhea.
Rilonacept, also known by the brand name <mark>Ilaris</mark>, is a medication used to treat specific inflammatory diseases. Here's a breakdown of its key points:
Conditions it treats:
- Cryopyrin-associated periodic syndromes (CAPS): This is a group of rare inherited disorders characterized by episodes of inflammation, fever, rash, joint pain, eye inflammation, and other symptoms. Rilonacept is specifically targeted for CAPS.
- Still's disease: This is a rare inflammatory disorder that can cause fever, joint pain, rash, and internal inflammation. Rilonacept is an option for treating a specific form of Still's disease called Systemic Juvenile Idiopathic Arthritis (SJIA) associated with high levels of interleukin-1 (IL-1), a signaling molecule involved in inflammation.
How it works:
- Rilonacept belongs to a class of drugs called interleukin-1 (IL-1) blockers. It works by specifically binding to IL-1, particularly IL-1α and IL-1β, which are key inflammatory signaling molecules. By blocking these molecules, Rilonacept helps reduce inflammation throughout the body, thereby alleviating symptoms of the targeted conditions.
Dosage and administration:
- Rilonacept is administered by subcutaneous injection (under the skin) typically once every four or eight weeks. The specific dosage and frequency will depend on the condition being treated and your doctor's recommendations.
Important considerations:
- Not a cure: Rilonacept is not a cure for CAPS or Still's disease, but it can help manage symptoms and reduce the frequency and severity of flare-ups.
- Side effects: Injection site reactions (pain, redness, swelling), upper respiratory infections, headache, and fatigue are some common side effects. Serious side effects are uncommon but can occur.
- Increased risk of infection: Rilonacept can suppress the immune system, slightly increasing the risk of infections. It's important to be vigilant about hygiene and inform your doctor promptly if you experience any signs of infection.
- Not for everyone: Rilonacept may not be suitable for people with certain medical conditions or allergies to the medication.
Anatomical Therapeutic Chemical Classification
L - Antineoplastic and immunomodulating agents
L04 Immunosuppressants
L04A - Immunosuppressants
L04AC Interleukin inhibitors
ATC Code
External Links
Rilonacept